AbbVie
ABBV
$0.18 (-0.11%)
1D
1W
3M
1Y
5Y
ALL
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
InvestorPlace • 1 day ago • ABBV
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in HealthcareMarketBeat • 1 day ago • ABBV
AbbVie Tracking for New Highs in 2024PRNewsWire • 2 days ago • ABBV
AbbVie to Present at the Bank of America Securities Healthcare ConferenceThe Motley Fool • 3 days ago • ABBV
3 Reasons to Buy AbbVie Stock on the DipZacks Investment Research • 7 days ago • ABBV
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending StockCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.